BPA for kymriah, fabhalta, netspot, and locametz
Active Awarded Last action
- Contract number
- 36E79726A0001
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 53% complete
- IDV ceiling
- $61,084,060.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Acquisition Center awarded a Blanket Purchase Agreement to Novartis Pharmaceuticals Corporation on October 2, 2025, with a ceiling of $61.084 million through October 1, 2027, for supply of four specialty pharmaceutical products: KYMRIAH, FABHALTA, NETSPOT, and LOCAMETZ under 2026 Public Law pricing.
The BPA is established against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Place of performance includes Novartis facilities nationwide: East Hanover, New Jersey (headquarters and primary manufacturing), Cary, North Carolina, Lake Mary, Florida, Phoenix, Arizona, Lebanon, Pennsylvania, Chicago, Illinois, San Antonio, Texas, West Haven, Connecticut, and Bethesda, Maryland, supporting VA and Defense Health Agency distribution channels.
NAICS 325412 (Pharmaceutical Preparation Manufacturing); PSC category Drugs and Biologicals. The BPA carries no small business set-aside.
Recent ordering activity under this vehicle reflects rapid acceleration of Novartis's specialty pharmaceutical footprint with the VA. The Veterans Integrated Service Network 22 issued delivery orders for PLUVICTO totaling $4.98 million (January 2, 2026), VISN 8 issued $4.73 million for PLUVICTO (February 24, 2026), and VISN 21 issued $3.4 million for LUTATHERA (October 1, 2025). The Defense Health Agency placed a $402.6 thousand purchase order for equipment maintenance services (August 15, 2025).
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79726A0001?
36E79726A0001 was awarded to Novartis Pharmaceuticals Corporation by National Acquisition Center (Headquarters) on October 2, 2025.
How much is contract 36E79726A0001 worth?
36E79726A0001's own ceiling is $61,084,060.
Who can order from contract 36E79726A0001?
36E79726A0001 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79726A0001 under another contract?
Yes. 36E79726A0001 is a blanket purchase agreement under 36F79720D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79726A0001 competed?
The extent of competition for 36E79726A0001 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV